RxDoctor Payments Data

Louis Giannone

Foot Surgery · Venice, FLNPI 1023001492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.

$3,627in general payments, 2019–2025

Across 41 payments — averaging $88.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanara Medtech Inc.$587
  • Linvatec Corporation$583
  • Convatec Inc.$276
  • Nevro Corp.$263
  • Next Science LLC$208
  • Abbott$176
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$3,627100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,627 in reported general payments places this provider in the 75th percentile of 107 foot surgery providers in Florida.

See all foot surgery providers in Florida

Medicare billing

Part B allowed, 2024
$299,864
Medicare patients
760
Services billed
3,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox72$1,930
Econazole Nitrate19$647
Doxycycline Hyclate64$439
Imiquimod19$391
Terbinafine Hcl20$173
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$108
Cephalexin23$89

Paid to pharmacies, not to this prescriber.

Other foot surgery in Venice

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →